syndrome

Interviews and expert commentary tagged “syndrome” — the latest oncology research and clinical practice from the Audio Journal of Oncology.

Non Drug Intervention: Better Than Antipsychotic Drugs for Aggressive Challenging Behaviour in Intellectual Disability
Audio Journal of Oncology

Non Drug Intervention: Better Than Antipsychotic Drugs for Aggressive Challenging Behaviour in Intellectual Disability

Peter Tyrer REFERENCE: Lancet 371:57 January 5, 2008 PETER TYRER, Imperial College, W6 8RP London A randomized study comparing treatment with risperidone, or haloperidol, or placebo to treat patients

4 January 2008
0:00
Live Report from ASH: Azacitidine ‘New Standard’ In High Risk Myelodysplastic Syndromes
Audio Journal of Oncology

Live Report from ASH: Azacitidine ‘New Standard’ In High Risk Myelodysplastic Syndromes

Pierre Fenaux PIERRE FENAUX, Paris 13 University Results from a phase III study presented at ASH suggest that the hypomethylating agent azacitidine should be the new standard of care for patients with

10 December 2007
0:00
TRITON-TIMI 38 Prasugrel Or Clopidogrel In Percutaneous Intevention?
Audio Journal of Oncology

TRITON-TIMI 38 Prasugrel Or Clopidogrel In Percutaneous Intevention?

Gordon Tomaselli Daniel Jones REFERENCE: Late Breaking Clinical Trials 1, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida GORDON TOMASELLI, Johns Hopkins Universit

5 November 2007
0:00
Heart Attacks Drop After Smoking Ban in Ireland
Audio Journal of Oncology

Heart Attacks Drop After Smoking Ban in Ireland

Edmond Cronin REFERENCE: Abstract 3506, European Society of Cardiology Congress, 2007, 1-5 September, Vienna, Austria EDMOND CRONIN, Cork University Hospital Study data that support banning smoking in

5 September 2007
0:00
Acute Coronary Syndromes: Big Mortality Reduction from Early Aggressive Statins
Audio Journal of Oncology

Acute Coronary Syndromes: Big Mortality Reduction from Early Aggressive Statins

Anthony Bavry, The Cleveland ClinIc, OH American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta. Abstract Number: 821-5 All cause mortality can be reduced by 25 per cent if

27 March 2006
0:00
Single Agent Bivalirudin Better for Acute Coronary Syndromes
Audio Journal of Oncology

Single Agent Bivalirudin Better for Acute Coronary Syndromes

Gregg Stone, Columbia University Medical Center, New York American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta A superiority for the anti-clotting drug bivalirudin for t

13 March 2006
1:07
Bivalirudin in ACS: The Acuity Study Findings
Audio Journal of Oncology

Bivalirudin in ACS: The Acuity Study Findings

Michael Lincoff, Cleveland Clilnic, Cleveland Ohio American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta The full picture of how bivalirudin is emerging as a treatment wi

13 March 2006
0:00